Journal of Proteomics & Bioinformatics
Open Access
ISSN: 0974-276X
ISSN: 0974-276X
Radiation Oncology Branch, National Cancer Institute, 10 Center Drive, Building 10, CRC, Bethesda, Maryland, USA
Reviewing pharmacology/toxicology data to ensure the safety of hematology/oncology products for patients in the USA. She is currently working as Pharmacology/toxicology reviewer in the Office of Hematology and Oncology Products Washington, District of Columbia, United States. She had completed her Phd. programme in topic CELL AND MOLECULAR PATHOLOGY from University of Michigan from year 2007-2013 . She has done her B.S. Biology from Villanova University from year 2001-2005.She graduated again in biological chemistry from FAES Graduate School at NIH from 2005-2007.
Research Article
The Quiescent Metabolic Phenotype of Glioma Stem Cells
Author(s): Elizabeth I Spehalski, Jennifer A Lee, Cord Peters, Philip Tofilon and Kevin Camphausen*
Introduction: Glioblastoma (GBM) is the most common primary malignant brain tumor in humans and, even with aggressive treatment that includes surgical resection, radiation (IR), and chemotherapy administration, prognosis is poor due to tumor recurrence. There is evidence that within GBMs a small number of glioma stem-like cells (GSLCs) exist, which are thought to be therapy resistant and are thus capable of repopulating a tumor after treatment. Like most cancers, GBMs largely employ aerobic glycolysis to create ATP, a phenomenon known as the Warburg Effect. There is no consensus on the metabolic characteristics of cancer stem cells. GSLCs have been shown to rely more heavily on oxidative phosphorylation, but there is also evidence that cancer stem cells can adapt their metabolism by fluctuating between energy pathways or acquiring intermediate metabolic phenotypes. We.. View More»
DOI:
10.35248/0974-276X.19.12.502